-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Sabra Health Care REIT, Raises Price Target to $23

Benzinga·11/16/2026 14:25:36
Listen to the news
Wells Fargo analyst James Feldman maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Overweight and raises the price target from $21 to $23.